Consolidated Statement of Changes in Stockholders' Equity Deficit - USD ($)
Total
Common Stock
Issued and Outstanding $0.001 Par
Common Stock
Committed to be issued $0.001 Par
Capital in Excess of Par Value
Deficit
Noncontrolling interests in Omagine LLC
Balances at Dec. 31, 2012 $ (847,473) $ 14,369 $ 107 $ 23,996,481 $ (24,867,849) $ 9,419
Balances (in shares) at Dec. 31, 2012   14,369,041 107,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Common Stock committed to stockholders relations agent for fees $ 107 $ (107)
Issuance of Common Stock committed to stockholders relations agent for fees (in shares)   107,500 (107,500)      
Issuance of Common Stock for cash $ 125,000 $ 100 $ 124,900
Issuance of Common Stock for cash (in shares)   100,000      
Stock option expense 1,445,744 1,445,744
Issuance of Common Stock for 401(k) Plan contribution 76,250 $ 55 76,195
Issuance of Common Stock for 401(k) Plan contribution (in shares)   55,253      
Stock options exercised by Director's estate 2,720 $ 4 2,716
Stock options exercised by Director's estate (in shares)   4,000      
Issuance of common stock for cash 75,000 $ 71 74,929
Restricted shares of Common Shares   71,162      
Stock grant to consultant for services rendered 5,330 $ 5 5,325
Stock grant to consultant for services rendered (in shares)   5,000      
Stock grants to stockholder relation agents for fees 38,540 $ 40 38,500
Stock grants to stockholder relation agents for fees (in shares)   40,000      
Issuance of Common Stock under New Standby Equity Distribution Agreement (New SEDA) 205,000 $ 164 204,836
Issuance of Common Stock under New Standby Equity Distribution Agreement (New SEDA) (in shares)   163,094      
Stock grant to IT consultants for fees 18,189 $ 20 $ 18,169
Stock grant to IT consultants for fees (in shares)   19,988      
Adjustments for noncontrolling interests in Omagine LLC (35,371) $ (35,371)
Net loss (2,640,590) $ (2,640,590)
Balances at Dec. 31, 2013 (1,531,661) $ 14,935 $ 25,987,795 $ (27,508,439) $ (25,952)
Balances (in shares) at Dec. 31, 2013   14,935,038      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock grant issued to law firm in satisfaction of $15,812 of accounts payable 26,248 $ 34 26,214
Stock grant issued to law firm in satisfaction of $15,812 of accounts payable, Shares   34,374      
Issuance of Common Stock for cash 1,487,100 $ 1,004 1,486,096
Issuance of Common Stock for cash (in shares)   1,004,629      
Stock option expense 3,486,856 3,486,856
Issuance of Common Stock for finders' fees on retricted Common Stock sales 76,168 $ 47 76,121  
Issuance of Common Stock for finders' fees on retricted Common Stock sales, Shares   46,000      
Issuance of Common Stock for 401(k) Plan contribution 76,250 $ 73 76,177
Issuance of Common Stock for 401(k) Plan contribution (in shares)   73,315      
Issuance of common stock for SEDA commitment fees 150,000 $ 86 149,914
Issuance of common stock for SEDA commitment fees (in shares)   85,822      
Issuance of Common Stock under New Standby Equity Distribution Agreement (New SEDA) 310,000 $ 219 309,781
Issuance of Common Stock under New Standby Equity Distribution Agreement (New SEDA) (in shares)   218,941      
Exercise of Tempest Warrants 663,500 $ 490 663,010
Exercise of Tempest Warrants(in shares)   490,000      
Cancellation of Restricted Common Stock to stockholder relations agent (9,020) $ (10) (9,010)
Cancellation of shares issued to stockholder relations agent (in shares)   (10,000)      
Issuance of Common Stock for 2014 SEDA commitment fees 150,000 $ 86 $ 149,914
Issuance of Common Stock for 2014 SEDA commitment fees (in shares)   85,822      
Adjustments for noncontrolling interests in Omagine LLC (53,669) $ (53,669)
Net loss (5,160,960) $ (5,160,960)
Balances at Dec. 31, 2014 (479,188) $ 16,878 $ 32,252,954 $ (32,669,399) $ (79,621)
Balances (in shares) at Dec. 31, 2014   16,878,119      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of Common Stock for cash 220,000 $ 206 219,794
Issuance of Common Stock for cash (in shares)   206,281      
Stock option expense 3,001 3,001
Issuance of Common Stock for finders' fees on retricted Common Stock sales 12,500 $ 8 12,492
Issuance of Common Stock for finders' fees on retricted Common Stock sales, Shares   7,911      
Issuance of Common Stock for 401(k) Plan contribution 76,250 $ 37 76,213
Issuance of Common Stock for 401(k) Plan contribution (in shares)   36,483      
Stock grant to consultant for services rendered 9,450 $ 5 9,445
Stock grant to consultant for services rendered (in shares)   5,000      
Issuance of Common Stock under New Standby Equity Distribution Agreement (New SEDA) 25,000 $ 18 24,982
Issuance of Common Stock under New Standby Equity Distribution Agreement (New SEDA) (in shares)   17,696      
Exercise of Tempest Warrants $ 250,000 $ 158 249,842
Exercise of Tempest Warrants(in shares)   158,228      
Cancellation of Restricted Common Stock to stockholder relations agent          
Issuance of Common Stock to an Executive Officer in payment of salaries payable $ 120,000 $ 100 119,900
Issuance of Common Stock to an Executive Officer in payment of salaries payable (in share)   100,000      
Stock Options exercised by former Director 1,020 $ 2 1,018
Stock Options exercised by former Director (in share)   2,000      
Issuance of Common Stock for Directors' Compensation for services September 1, 2015 to December 31, 2015 100,000 $ 50 99,950
Issuance of Common Stock for Directors' Compensation for services September 1, 2015 to December 31, 2015, (in shares)   50,000      
Issuance of Restricted Common Stock for cash 14,700 $ 10 14,690
Issuance of Restricted Common Stock for cash (in shares)   10,000      
Stock Option expense - Extension of Strategic Options (1,965,000 to December 31, 2016) 915,493 915,493
Stock Option expense - Extension of Strategic Options (950,000 to December 31, 2016) 541,215 541,215
Payment-in-Kind capital contribution of land by noncontrolling interest in Omagine LLC 718,614,000 431,168,400 $ 287,445,600
Stock Option expense - Stock Appreciation Rights (1,455,000 expiring December 31, 2017) 1,654,481 1,654,481
Adjustments for noncontrolling interests in Omagine LLC (102,160)         $ (102,160)
Net loss (4,935,261)       $ (4,935,261)  
Balances at Sep. 30, 2015 $ 717,040,501 $ 17,472 $ 467,363,870 $ (37,604,660) $ 287,263,819
Balances (in shares) at Sep. 30, 2015   17,471,718